FDA clears DEXTER for ventral hernia repair

Aug 13, 2026 · Regulatory · Distalmotion · Surgical

The U.S. Food and Drug Administration granted 510(k) clearance for use of Distalmotion's DEXTER robotic surgery system in ventral hernia repair.

Distalmotion company media
Company media · Distalmotion

Evidence notes

  • The clearance expands DEXTER's U.S. label to the four highest-volume soft-tissue ambulatory procedure categories.
  • Distalmotion reports that surgeons have used DEXTER in more than 4,000 patients.
  • The system is designed for surgeon-controlled robotic assistance within established operating-room workflows.

Links